REMINDER: The ACS would never email, call, or text asking for your personal details like IDs, passwords, or account numbers. Safeguard your cybersecurity by being vigilant against phishing messages, not connecting to public Wi-Fi, and verifying the identity of unexpected phone callers.
Unsupported Browser
The American College of Surgeons website is not compatible with Internet Explorer 11, IE 11. For the best experience please update your browser.
Menu
Become a member and receive career-enhancing benefits

Our top priority is providing value to members. Your Member Services team is here to ensure you maximize your ACS member benefits, participate in College activities, and engage with your ACS colleagues. It's all here.

Become a Member
Become a member and receive career-enhancing benefits

Our top priority is providing value to members. Your Member Services team is here to ensure you maximize your ACS member benefits, participate in College activities, and engage with your ACS colleagues. It's all here.

Membership Benefits
ACS
Bulletin

Coming next month in JACS and online now: Outcomes after pancreatectomy with routine pasireotide use

Adoption of pasireotide during routine surgical practice allowed for achievement of clinically significant abscess or pancreatic leak rate of 13.3 percent.

ACS

January 4, 2019

John W. Kunstman, MD; Debra A. Goldman, MS; Mithat Gönen, PhD, et al report in the February issue of the Journal of the American College of Surgeons (JACS) on their findings that adoption of pasireotide allowed for achievement of clinically significant abscess or pancreatic leak rate of 13.3 percent, approximating the effect observed in a randomized trial of pasireotide during routine surgical practice.

This article and all other JACS content is available on the JACS website.